Yale's quantum computing journey — 20 years and counting
Yale’s Robert Schoelkopf, Michel Devoret, and Steven Girvin reflect on their trailblazing approach to quantum computing research.
Stay updated with breaking news from Brita Belli. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Yale’s Robert Schoelkopf, Michel Devoret, and Steven Girvin reflect on their trailblazing approach to quantum computing research.
KAT6 is an emerging target in hormone sensitive breast tumors and other cancers. Overexpression of KAT6A/B correlates with poor clinical outcomes in patients...
Despite artificial intelligence’s growing role in drug research, a fully AI-generated molecule has yet to advance from discovery all the way through clinical development. A novel molecule may eventually meet that goal, but some industry observers say it’s too early to focus on winning a race that has many twists and turns yet to come.
A review of The Autism Puzzle: Connecting the Dots Between Environmental Toxins and Rising Autism Rates by Brita Belli